IL17A vaccine has been used to treat IL17A-related autoimmune disorders.29–32 IL17A vaccine was first developed to prevent experimental autoimmune encephalomyelitis (EAE) in an animal model in 2006. Here, IL17A is linked to experimental autoimmune encephalomyelitis.